Current approaches to the morphological diagnosis of pancreatic neuroendocrine tumors and prediction of their clinical course based on the analysis of our own database
Aim: Combined clinical and morphological analysis of the pancreatic neuroendocrine tumor (pNET) spectrum according to the new World Health Organization classification: patient distribution, hormonal status, morphological grading, somatostatin receptor 2 (SSR2) and 5 (SSR5) expression, the choice of...
Main Authors: | L. E. Gurevich, I. A. Kazantseva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
MONIKI
2018-09-01
|
Series: | Alʹmanah Kliničeskoj Mediciny |
Subjects: | |
Online Access: | https://www.almclinmed.ru/jour/article/view/848 |
Similar Items
-
Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy
by: Yuheng Hu, et al.
Published: (2021-05-01) -
THE PROGNOSTIC AND DIFFERENTIAL DIAGNOSTIC VALUE OF CYTOKERATIN 7 AND 19, AND THYROID TRANSCRIPTION FACTOR-1 EXPRESSION IN LUNG NEUROENDOCRINE TUMORS OF VARIOUS GRADES
by: L. E. Gurevich, et al.
Published: (2017-01-01) -
Long-Term Disease Control of a Pancreatic Neuroendocrine Tumor with Lanreotide Autogel®: A Case Report
by: Willem Lybaert, et al.
Published: (2014-09-01) -
Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology
by: Xu Han, et al.
Published: (2018-02-01) -
Role of Somatostatin Signalling in Neuroendocrine Tumours
by: Olesja Rogoza, et al.
Published: (2022-01-01)